Cardiovascular

Cloud Ear (Auricularia polytricha, now often classified as A. cornea) is a widely cultivated gelatinous fungus used in TCM for over a millennium to treat blood stasis and promote cardiovascular health. Its acidic polysaccharides with high glucuronic acid content create heparin-like anticoagulant effects through antithrombin III enhancement, while adenosine provides antiplatelet activity via A2A receptor activation. Preclinical studies demonstrate significant antithrombotic, lipid-lowering, antioxidant, and anti-inflammatory activities. Closely related to A. auricula-judae, with overlapping pharmacology but potentially distinct polysaccharide structural profiles. Important drug interaction warnings exist for concurrent anticoagulant and antiplatelet therapy.

Claviceps purpurea (ergot) is a parasitic fungus of cereal grains that produces a remarkable array of alkaloids -- ergotamine, ergometrine, dihydroergotamine, and lysergic acid derivatives -- that have profoundly shaped both medical history and pharmacology. Ergot alkaloids act on serotonin, dopamine, and adrenergic receptors, forming the basis for treatments of migraine (ergotamine, DHE), postpartum hemorrhage (ergometrine), Parkinson's disease and hyperprolactinemia (bromocriptine, cabergoline), and historically contributing to the synthesis of LSD. Approximately 130 epidemics of ergotism ("St. Anthony's fire") were documented in Europe between 591 and 1789 AD. Modern clinical use is restricted to purified and semi-synthetic derivatives due to the narrow therapeutic index and complex receptor pharmacology of crude ergot preparations.

Auricularia heimuer (Heimuer/Chinese Wood Ear) is the actual species of commerce for the globally traded "black wood ear" or "mu er" -- one of the most cultivated mushrooms in the world with over 6 million tonnes annual production in China alone. It was long misidentified as A. auricula-judae until taxonomic revision in 2015. In TCM, it is classified as a blood-vitalizing medicine with demonstrated anticoagulant (adenosine-mediated antiplatelet), lipid-lowering (polysaccharide-mediated), and antioxidant activities. Small clinical trials support improvements in blood lipid profiles and hemorheological parameters. Its dual status as both food and medicine in China makes it one of the most accessible medicinal fungi globally.

King Oyster Mushroom (Pleurotus eryngii) is a widely cultivated edible mushroom that contains naturally occurring lovastatin (an HMG-CoA reductase inhibitor), beta-glucans, and ergothioneine -- a potent cellular antioxidant. Randomized controlled trials in metabolically unhealthy obese adults demonstrate improved postprandial glycemia, reduced body weight and fat, decreased inflammatory markers (IL-6, oxidized LDL), and enhanced ghrelin regulation. While preclinical evidence for cholesterol reduction is strong, large-scale human cardiovascular outcome trials are still needed. Its dual identity as a premium culinary mushroom and functional food makes it uniquely accessible for dietary integration.

Pleurotus ostreatus (Oyster Mushroom) is the world's second most cultivated edible mushroom and uniquely contains naturally occurring lovastatin -- the same HMG-CoA reductase inhibitor approved as a cholesterol-lowering pharmaceutical. Clinical trials demonstrate cholesterol-lowering and hypoglycemic effects, while its beta-glucan (pleuran) has shown immunomodulatory activity in controlled studies. The combination of a well-characterized pharmaceutical compound (lovastatin) in a food-safe matrix, alongside immunomodulatory polysaccharides and the potent antioxidant ergothioneine, positions oyster mushroom as a uniquely evidence-based functional food for cardiovascular health.

Pleurotus pulmonarius (Phoenix Oyster) is a warm-weather oyster mushroom species that produces significantly higher levels of lovastatin -- a naturally occurring cholesterol-lowering compound -- than its close relative P. ostreatus. It also contains pleuran (beta-1,3/1,6-glucan) with demonstrated immunomodulatory properties, ergothioneine (a cellular antioxidant), and phenolic compounds with anti-inflammatory effects. While clinical trials specific to P. pulmonarius are limited, preclinical evidence for cholesterol reduction, immune stimulation, and antioxidant activity is substantial, and genus-level clinical data from Pleurotus species supports a moderate evidence rating. It is widely cultivated in tropical and subtropical regions as a protein-rich food source.

Pleurotus djamor (Pink Oyster Mushroom) is a fast-growing tropical oyster mushroom species containing naturally occurring lovastatin, the same HMG-CoA reductase inhibitor found in its close relative P. ostreatus. Preclinical studies demonstrate antioxidant activity comparable to ascorbic acid, antimicrobial effects against pathogenic bacteria, and antidiabetic potential through alpha-glucosidase inhibition. While no human clinical trials exist specifically for P. djamor, its lovastatin content and high-protein nutritional profile position it as a promising functional food for cardiovascular and metabolic health.

Wood Ear (Auricularia auricula-judae) is one of the most consumed edible fungi globally and a staple of Chinese cuisine with over 1,500 years of documented medicinal use. Its unique acidic polysaccharides act as heparin-like anticoagulants through antithrombin III enhancement, while adenosine provides antiplatelet activity — creating a multi-target cardiovascular protection profile. Clinical trials demonstrate significant lipid-lowering, blood viscosity-reducing, and antiplatelet effects. TCM Pharmacopoeia listed, it is exceptionally rich in iron (97 mg/100g dried) and dietary fiber. The clinically relevant anticoagulant activity creates important drug interaction warnings with blood-thinning medications.